Transformative Partnership: Zydus and Guardant Health Join Forces for Cancer Testing in India and Nepal
As India and Nepal grapple with the growing burden of cancer cases, initiatives like these are pivotal in steering the healthcare landscape towards innovative solutions ...
BharatBiotechâ€™s Covaxin is now available for children of age 6+
The Drugs Controller General of India (DCGI) has given BharatBiotechâ€™s Covaxin restricted emergency use authorisation. This vaccine can now be used for children between ...
Full dose of Zydus Cadila's Covid vaccine at Rs 1,128
Zycov-D is the first DNA Plasmid vaccine...
Introduction to hearing loss and deafness with harmful effects of earphones in words of Dr. Lav Selarka
Dr. Lav Selarka gives a pictorial presentation of the Anatomy of the ear. Dr. Lav also emphasizes early diagnosis of hearing problems and the side ...
Covaxin gets EUA for children aged 2-18 years
The Subject Expert Committee (SEC) has approved emergency use of Bharat Biotech's Covaxin for children in the 2-18 years age group...
First needle less COVID vaccines for children and adult above 12 years got approval for EUA
Zydus Cadilaâ€™s ZyCov-D, Covid vaccine got Emergency Use Authorization for children and adults 12 years and above
Country soon to get worldâ€™s first DNA-plasmid vaccine by Zydus Cadilla: Chairman COVID-19 NTAGI
Zydus Cadila vaccine to be available by September...
Zydus Cadila receives tentative approval from USFDA for Pemetrexed for Injection
used to treat certain types of cancers such as lung cancer, mesothelioma. It is a chemotherapy drug that works
by slowing or stopping ...
Zydus Cadila receives tentative approval from USFDA for Fingolimod Capsules .25mg
It is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS)....
Zydus and Bayer announce continuity of their successful Joint Venture
Bayer Zydus Pharma has been a successful partnership combining Bayerâ€™s scientific expertise and commercialization of novel products backed by Cadila Healthcareâ€™s strong India ...
Zydus Cadila receives tentative approval from USFDA for Brivaracetam Tablet
Brivaracetam is used to treat partial-onset of seizures (epilepsy)...
Wide variety of therapies to address autism in children explained by Dr. Shilpa Jasubhai, Clinical Psychologist
Children with Autism have something very particular or special in them like they may be good with numbers or good at solving puzzles. Parents and ...
Dissociative Identity Disorder explained by Dr. Shilpa Jasubhai, Clinical Psychologist
Dr. Shilpa Jasubhai, Clinical Psychologist, highlights main traits of dissociative Identity disorder, healing strategies from DID, how to help a friend suffering from this disorder ...
Zydus Cadila receives final approval from USFDA for Liothyronine Sodium Tablets
Liothyronine is a man-made form of thyroid hormone which is used to treat an underactive thyroid (hypothyroidism)....
India signs purchase order with Serum for AstraZeneca vaccine
India has signed a purchase order with vaccine producer Serum Institute to procure AstraZenecaâ€™s COVID-19 vaccine, a source said on Monday, the first ...
Top Ten Pharma Companies of India : January 2021
Top ten pharma stocks January 2021...
India approves AstraZeneca's COVID-19 vaccine
India has approved the COVID-19 vaccine developed by AstraZeneca and Oxford University, paving the way for a huge immunization campaign in the worldâ€™s ...
Zydus announces the approval of Saroglitazar Mg for the treatment of Non-Alcoholic fatty Liver disease in India
About 25 to 30% of Indian population suffers from NALD...
India readies for 600 million COVID vaccine jabs; to use standard cold storage - top government expert
India will deploy its vast election machinery to deliver 600 million doses of COVID-19 vaccines to the most vulnerable people in the next six ...
A New Digital platform 'CO-WIN' is being used for COVID-19 Vaccination Delivery
In India, A new digital platform, called 'CO-WIN' is being used for the delivery of COVID 19 Vaccination....
Zydus granted fast track designation by the USFDA for Saroglitazar in the treatment of patients with PBC
Fast Track is a process of the USFDA which expedites the review of drugs to treat serious conditions and fill an unmet medical need...
India in the forefront of developing COVID-19 vaccines: Dr Harsh Vardhan
United Kingdom to become first country to roll out COVID-19 vaccine
As per the British government, the shots will be initially available at hospitals before distributing stocks to doctors' clinics...
Zydus announces Phase I trials of ZYIL1, a novel oral small molecule NLRP3 inflammasome inhibitor
Zydus, today announced that it has received permission to initiate the Phase 1 clinical trial of ZYIL1, a novel oral small molecule NLRP3 inhibitor candidate....
Serum Institute applies for Emergency Use approval from DCGI : Covid-19 Vaccine
Serum and Pfizer applies for emergency use authorisation from DCGI...
|25 Matching result(s) found!
|Worldwide EndoMarch, Endo Run to raise mass awareness on Endometriosis!February 21, 2024
|Uptick In Respiratory, and Cardiac Problems Due To Poor Air Quality In DelhiFebruary 21, 2024
|Evidence shows risks associated with energy drinks in childrenFebruary 21, 2024
|iHub-Data at IT-Hyderabad announces collaborative initiative with technical institutions for AI/ML training programsFebruary 20, 2024
|Viatris Receives Global Minimized Risk of Antimicrobial Resistance Certification, Advancing its Commitment to Responsible Antibiotic ProductionFebruary 20, 2024
|“Kusum Ka Biyaah” Indian Hindi film based on a true story releasing on 1st March 2024February 19, 2024
|Introducing Moscow's Pioneering Initiative: An Open Dataset for AI-driven Brain Disease Detection"February 19, 2024
|ICPA Health Products Introduces Coolora Spray - A Rapid Relief Solution For Oral & Throat DiscomfortFebruary 19, 2024
|Section 43B of the Income Tax demystifiedFebruary 16, 2024
|Nutricircle Introduces Health Supplements My45NutrientsTM to Enhance Overall Well-beingFebruary 16, 2024
|YFLO organised a session “Design Your Story” to inspire young FICCI Ladies to design their own compelling storiesFebruary 15, 2024
|149 experts call to find all TB to stop TBFebruary 15, 2024
|ICPA Welcomes Global Leader In Periodontal Aesthetics - Prof Giovanni Zucchelli On His Inaugural Visit To IndiaFebruary 14, 2024
|Fast Fashion and Sustainability are not friends and do not go well with each other: Namrata Joshipura, one of India’s most celebrated Fashion designers February 14, 2024
|YFLO to organise a session Design Your StoryFebruary 14, 2024
|Starkey Launches Genesis AI Hearing Aids in India, Pioneering a New Era in Hearing HealthFebruary 14, 2024
|Indian Institute of Heritage and University of Birmingham announce strategic partnershipFebruary 14, 2024
|Siddharth Anand’s Fighter emerges as the first hit of 2024February 13, 2024
|India’s 26 years old youth’s Adventurous Atal Yatra to Celebrate Silver Jubilee of the Golden Quadrilateral beginsFebruary 13, 2024
|Vitafoods India 2024 - Exploring Nutraceutical FrontiersFebruary 13, 2024